Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Table of Contents

March 01, 2025; Volume 92,Issue 3

From the Editor

  • You have access
    All sulfa drugs are not created equal
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 136-137; DOI: https://doi.org/10.3949/ccjm.92b.03025

    Misinformation about “sulfa allergy” can result in unnecessary avoidance of useful medications and the prescription of less effective alternatives.

The Clinical Picture

  • You have access
    Sarcoidosis with diffuse purplish erythematous plaques on the hands
    Akihiro Orita, MD and Mitsuhito Ota, MD, PhD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 145-146; DOI: https://doi.org/10.3949/ccjm.92a.24022

    A 70-year-old woman presented in winter with a 1-month history of asymptomatic redness of the hands.

1-Minute Consult

  • You have access
    Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
    Nicholas B. Cline, MD, Amudha Pazhanisamy, DO and David M. Lang, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 147-151; DOI: https://doi.org/10.3949/ccjm.92a.24054

    There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.

Guidelines to Practice

  • You have access
    Hyperglycemic crises in adults: A look at the 2024 consensus report
    CME article
    Paloma Rodriguez Alvarez, MD, Vicente T. San Martin, MD and Oscar L. Morey-Vargas, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 152-158; DOI: https://doi.org/10.3949/ccjm.92a.24089

    A new report introduces revised criteria for the diagnosis of diabetic ketoacidosis and hyperglycemic hyperosmolar state, as well as new recommendations for assessment, management, and prevention of these disorders.

Review

  • You have access
    Cardiovascular disease in people living with HIV: Risk assessment and management
    Elizabeth Ghandakly, MD, JD, Rohit Moudgil, MD, PhD and Katherine Holman, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 159-167; DOI: https://doi.org/10.3949/ccjm.92a.24055

    Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.

Editorial

  • You have access
    Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
    James Hekman, MD and Henry H. Ng, MD, MPH
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 168-170; DOI: https://doi.org/10.3949/ccjm.92a.24126

    The already higher cardiovascular risk in people living with HIV is exacerbated by social determinants of health such as socioeconomic status, access to healthcare, and systemic discrimination. Interventions that address this risk must be based in medical science and equity.

Review

  • You have access
    Psychedelic-assisted therapy: An overview for the internist
    Brian S. Barnett, MD, Erin E. Mauney, MD and Franklin King, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 171-180; DOI: https://doi.org/10.3949/ccjm.92a.24032

    The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.

  • Coronary artery bypass grafting: Practice trends and projections
    You have access
    Coronary artery bypass grafting: Practice trends and projections
    Richard Ramsingh, MD and Faisal G. Bakaeen, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 181-191; DOI: https://doi.org/10.3949/ccjm.92a.23071

    Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.

Letters to the editor

  • You have access
    Effective but inaccessible antiobesity medications
    Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001
  • You have access
    Classic diabetic ketoacidosis and the euglycemic variant
    Param Darpan Sheth, MBBS
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 142; DOI: https://doi.org/10.3949/ccjm.92c.03002
  • You have access
    In Reply: Classic diabetic ketoacidosis and the euglycemic variant
    Adi E. Mehta, MD and Robert Zimmerman, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 142-143; DOI: https://doi.org/10.3949/ccjm.92c.03003
  • You have access
    Insomnia in older adults
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 143-144; DOI: https://doi.org/10.3949/ccjm.92c.03004
  • You have access
    In Reply: Insomnia in older adults
    Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 92 (3)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 3
1 Mar 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Psychedelic-assisted therapy: An overview for the internist
  • Hyperglycemic crises in adults: A look at the 2024 consensus report
  • Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
Sign up for alerts

Jump to

  • From the Editor
  • The Clinical Picture
  • 1-Minute Consult
  • Guidelines to Practice
  • Review
  • Editorial
  • Review
  • Letters to the editor
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
The beat goes on: Highlights from the new American and European A-fib guidelines
What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Tinea incognito
Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Sarcoidosis with diffuse purplish erythematous plaques on the hands
Cardiovascular disease in people living with HIV: Risk assessment and management
Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Don’t judge a book by its cover: Unusual presentations of pericardial disease
Hypoglycemia after bariatric surgery: Management updates
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Common electrolyte imbalance, uncommon cause

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire